SOLUBLE CADHERIN 17 FOR THE DIAGNOSIS AND RISK STRATIFICATION OF CANCER AND TUMOUR OF THE GASTROINTESTINAL TRACT

摘要

The invention relates to a method for the diagnosis and risk stratification of tumour or cancer of the gastrointestinal tract, especially bowel tumour or bowel cancer, wherein a determination takes place on at least one patient by means of the novel biomarker of soluble cadherin 17 - a proteolytic cleavage product of cadherin 17 having SEQ ID No. 1 or SEQ ID No. 2 - or partial peptides and fragments thereof.